UB Paderborn / Katalog / Suche / in CDI

An ESPGHAN Position Paper on the Use of Low‐FODMAP Diet in Pediatric Gastroenterology

Journal of pediatric gastroenterology and nutrition, 2022-09, Vol.75 (3), p.356-368

2022

Volltextzugriff (PDF)

The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update

Journal of Crohn's and colitis, 2021-02, Vol.15 (2), p.171-194

2021

Volltextzugriff (PDF)

Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Evidence-based Guideline From European Crohnʼs and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition

Journal of pediatric gastroenterology and nutrition, 2018-08, Vol.67 (2), p.257-291

2018

Volltextzugriff (PDF)

Infliximab dependency in children with Crohn’s disease

Alimentary pharmacology & therapeutics, 2009-04, Vol.29 (7), p.792-799

2009

Volltextzugriff (PDF)

Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis—An Evidence-based Consensus Guideline From the European Crohnʼs and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition

Journal of pediatric gastroenterology and nutrition, 2018-08, Vol.67 (2), p.292-310

2018

Volltextzugriff (PDF)

Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss

Journal of clinical laboratory analysis, 2008, Vol.22 (5), p.380-382

2008

Volltextzugriff (PDF)

ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Vitamins

Clinical nutrition (Edinburgh, Scotland), 2018-12, Vol.37 (6), p.2366-2378

2018

Volltextzugriff (PDF)

Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines

Journal of pediatric gastroenterology and nutrition, 2012-09, Vol.55 (3), p.340-361

2012

Volltextzugriff (PDF)

P853 Factors associated with intestinal tissue levels of anti-TNF in pediatric patients with Crohn's Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1582-i1582

2024

Volltextzugriff (PDF)

Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry

Inflammatory bowel diseases, 2013-02, Vol.19 (2), p.378-385

2013

Volltextzugriff (PDF)

Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry

Inflammatory bowel diseases, 2013-02, Vol.19 (2), p.370-377

2013

Volltextzugriff (PDF)

P911 The changes in the faecal microbiome and metabolome in Crohn’s disease after treatment with anti-TNFα antibodies are of secondary origin

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i1023-i1025

2023

Volltextzugriff (PDF)

P1130 Predictors of Remission within One Year of Advanced Therapy in Paediatric Patients with Ulcerative Colitis – analysis from Czech national registry of biologic treatment (CREdIT)

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i2024-i2024

2024

Volltextzugriff (PDF)

Early diagnostic markers of sepsis after oesophagectomy (including thromboelastography)

BMC anesthesiology, 2012-06, Vol.12 (1), p.12-12, Article 12

2012

Volltextzugriff (PDF)

Diagnostic Workup of Paediatric Patients With Inflammatory Bowel Disease in Europe: Results of a 5-Year Audit of the EUROKIDS Registry

Journal of pediatric gastroenterology and nutrition, 2012-03, Vol.54 (3), p.374-380

2012

Volltextzugriff (PDF)

Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD group

Inflammatory bowel diseases, 2014-02, Vol.20 (2), p.291-300

2014

Volltextzugriff (PDF)

P119 The immunohistochemical assessment of CD30+ lymphocytes in the intestinal mucosa facilitates diagnosis of paediatric ulcerative colitis

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S152-S152

2018

Volltextzugriff (PDF)

P590 Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i526-i527

2022

Volltextzugriff (PDF)

P365 Identification of predictive factors of AZA/6-MP treatment outcome in paediatric luminal Crohn’s disease: a multicentre study of the paediatric IBD Porto group of ESPGHAN

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S346-S346

2020

Volltextzugriff (PDF)

Amylin fasting plasma levels are decreased in patients with osteoporosis

Osteoporosis international, 2004-03, Vol.15 (3), p.243-247

2004

Volltextzugriff (PDF)

Severe gastric ulcer as a first manifestation of systemic lupus erythematosus in a child

Gastroenterologie a hepatologie, 2017-12, Vol.71 (6), p.483-486

2017

Volltextzugriff (PDF)

P734 Anti-TNFa exposure during pregnancy is not associated with increased infection risk in exposed children during the first year of life

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S482-S483

2018

Volltextzugriff (PDF)

P460 Impact of anti-TNFα exposure during pregnancy for maternal inflammatory bowel disease on serologic response to vaccination of exposed children

Journal of Crohn's and colitis, 2018-01, Vol.12 (supplement_1), p.S337-S337

2018

Volltextzugriff (PDF)

P302 Cytomegalovirus infection in pediatric acute severe ulcerative colitis – a multicenter case-controlled study from the Pediatric IBD Porto group of ESPGHAN

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S231-S231

2017

Volltextzugriff (PDF)

P194 Anti-TNFα treatment following surgical resection for Crohn's disease is effective despite previous pharmacodynamic failure

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S175-S175

2017

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

An ESPGHAN Position Paper on the Use of Low‐FODMAP Diet in Pediatric Gastroenterology

The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update

Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care—An Evidence-based Guideline From European Crohnʼs and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition

Infliximab dependency in children with Crohn’s disease

Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis—An Evidence-based Consensus Guideline From the European Crohnʼs and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition

Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss

ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Vitamins

Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines

P853 Factors associated with intestinal tissue levels of anti-TNF in pediatric patients with Crohn's Disease

Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry

Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry

P911 The changes in the faecal microbiome and metabolome in Crohn’s disease after treatment with anti-TNFα antibodies are of secondary origin

P1130 Predictors of Remission within One Year of Advanced Therapy in Paediatric Patients with Ulcerative Colitis – analysis from Czech national registry of biologic treatment (CREdIT)

Early diagnostic markers of sepsis after oesophagectomy (including thromboelastography)

Diagnostic Workup of Paediatric Patients With Inflammatory Bowel Disease in Europe: Results of a 5-Year Audit of the EUROKIDS Registry

Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD group

P119 The immunohistochemical assessment of CD30+ lymphocytes in the intestinal mucosa facilitates diagnosis of paediatric ulcerative colitis

P590 Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel

P365 Identification of predictive factors of AZA/6-MP treatment outcome in paediatric luminal Crohn’s disease: a multicentre study of the paediatric IBD Porto group of ESPGHAN

Amylin fasting plasma levels are decreased in patients with osteoporosis

Severe gastric ulcer as a first manifestation of systemic lupus erythematosus in a child

P734 Anti-TNFa exposure during pregnancy is not associated with increased infection risk in exposed children during the first year of life

P460 Impact of anti-TNFα exposure during pregnancy for maternal inflammatory bowel disease on serologic response to vaccination of exposed children

P302 Cytomegalovirus infection in pediatric acute severe ulcerative colitis – a multicenter case-controlled study from the Pediatric IBD Porto group of ESPGHAN

P194 Anti-TNFα treatment following surgical resection for Crohn's disease is effective despite previous pharmacodynamic failure

Suchergebnisse filtern